These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17393747)

  • 1. Quality and clinical efficacy of allergen mixtures.
    Malling HJ
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):253-7; discussion 257. PubMed ID: 17393747
    [No Abstract]   [Full Text] [Related]  

  • 2. Standards for practical allergen-specific immunotherapy.
    Alvarez-Cuesta E; Bousquet J; Canonica GW; Durham SR; Malling HJ; Valovirta E;
    Allergy; 2006; 61 Suppl 82():1-20. PubMed ID: 16930249
    [No Abstract]   [Full Text] [Related]  

  • 3. Standardization of allergen extracts.
    Matthiesen F
    Z Hautkr; 1988; 63 Suppl 4():52-4. PubMed ID: 3252626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural allergen extracts: is there a future in allergy diagnosis and therapy?
    Lehrer SB; Reese G
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):73-8; discussion 79. PubMed ID: 9383893
    [No Abstract]   [Full Text] [Related]  

  • 5. [Purification and standardization of allergens].
    Guérin B
    Rev Med Suisse Romande; 1994 Mar; 114(3):251-4. PubMed ID: 8171235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardisation of allergens in Europe.
    Sjöholm I
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):107-10. PubMed ID: 9383897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardization of allergen extracts for immunotherapy: where do we stand?
    Becker WM; Vogel L; Vieths S
    Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):470-5. PubMed ID: 17088654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EAACI 'Standards for practical allergen-specific immunotherapy'.
    Madsen F
    Allergy; 2007 Mar; 62(3):332. PubMed ID: 17298352
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to the letter by Dr Fleming Madsen (EAACI 'Standards for practical allergen-specific immunotherapy').
    Alvarez-Cuesta E; Bousquet J; Canonica WG; Durham S; Malling HJ; Passalacqua G; Valovirta E
    Allergy; 2008 Jul; 63(7):939-40. PubMed ID: 18588562
    [No Abstract]   [Full Text] [Related]  

  • 10. Preparing and mixing allergen vaccines.
    Nelson HS
    Clin Allergy Immunol; 2004; 18():457-79. PubMed ID: 15042929
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant allergens; basic and practical considerations.
    Breiteneder H; Hoffmann-Sommergruber K; Vanek-Krebitz M; Kraft D; Scheiner O
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):80-6. PubMed ID: 9383894
    [No Abstract]   [Full Text] [Related]  

  • 12. [Governmental batch sample testing of allergen products].
    Bartel D; Führer F; Vieths S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Mar; 55(3):358-62. PubMed ID: 22373849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification.
    van Ree R; Chapman MD; Ferreira F; Vieths S; Bryan D; Cromwell O; Villalba M; Durham SR; Becker WM; Aalbers M; André C; Barber D; Cistero Bahima A; Custovic A; Didierlaurent A; Dolman C; Dorpema JW; Di Felice G; Eberhardt F; Fernandez Caldas E; Fernandez Rivas M; Fiebig H; Focke M; Fötisch K; Gadermaier G; Das RG; Gonzalez Mancebo E; Himly M; Kinaciyan T; Knulst AC; Kroon AM; Lepp U; Marco FM; Mari A; Moingeon P; Monsalve R; Neubauer A; Notten S; Ooievaar-de Heer P; Pauli G; Pini C; Purohit A; Quiralte J; Rak S; Raulf-Heimsoth M; San Miguel Moncin MM; Simpson B; Tsay A; Vailes L; Wallner M; Weber B
    Allergy; 2008 Mar; 63(3):310-26. PubMed ID: 18269676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MMW Drug Prize 2008 awarded. SQ allergens allow allergic patients to breathe deeply].
    Wepner U
    MMW Fortschr Med; 2008 Jun; 150(26-27):21. PubMed ID: 18681225
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of allergenic products in the United States: the promise and problem of adjuvants in allergen immunotherapy.
    Rabin RL
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():219-22; discussion 223. PubMed ID: 20799464
    [No Abstract]   [Full Text] [Related]  

  • 16. Allergen extract standardization: reality, myth, or dream?
    Dolen WK
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):81-2. PubMed ID: 7648386
    [No Abstract]   [Full Text] [Related]  

  • 17. Current problems of regulation of allergenic extracts in Germany.
    Haustein D
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):123-6. PubMed ID: 9383900
    [No Abstract]   [Full Text] [Related]  

  • 18. Epicutaneous allergen administration: a novel approach for allergen-specific immunotherapy?
    Werfel T
    J Allergy Clin Immunol; 2009 Nov; 124(5):1003-4. PubMed ID: 19895988
    [No Abstract]   [Full Text] [Related]  

  • 19. [Modern technics and treatments of specific desensitization. The delayed-action allergen].
    Vallery-Radot C
    Clinique (Paris); 1965 Jun; 60(608):399-405. PubMed ID: 5845014
    [No Abstract]   [Full Text] [Related]  

  • 20. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.